CpG oligonucleotides improve the protective immune response induced by the anthrax vaccination of rhesus macaques.
about
Anthrax vaccination strategiesAnthrax prevention and treatment: utility of therapy combining antibiotic plus vaccine.In vivo efficacy of a phosphodiester TLR-9 aptamer and its beneficial effect in a pulmonary anthrax infection modelImmunostimulatory CpG oligonucleotides: Effect on gene expression and utility as vaccine adjuvantsCombinatorial Delivery of Dual and Triple TLR Agonists via Polymeric Pathogen-like Particles Synergistically Enhances Innate and Adaptive Immune Responses.CpG oligodeoxynucleotides adsorbed onto polylactide-co-glycolide microparticles improve the immunogenicity and protective activity of the licensed anthrax vaccineTLR-based immune adjuvants.CpG DNA as a vaccine adjuvant.A CpG-Ficoll Nanoparticle Adjuvant for Anthrax Protective Antigen Enhances Immunogenicity and Provides Single-Immunization Protection against Inhaled Anthrax in Monkeys.A TLR9 agonist enhances the anti-tumor immunity of peptide and lipopeptide vaccines via different mechanismsSystemic but not mucosal immunity induced by AVA prevents inhalational anthraxCpG oligonucleotides accelerate and boost the immune response elicited by AVA, the licensed anthrax vaccine.CpG oligonucleotides improve the protective immune response induced by the licensed anthrax vaccine.Stochastic humoral immunity to Bacillus anthracis protective antigen: identification of anti-peptide IgG correlating with seroconversion to Lethal Toxin neutralizationSynthetic oligonucleotides as modulators of inflammationEffect of CpG oligonucleotides on vaccine-induced B cell memory.Use of nanoparticles to deliver immunomodulatory oligonucleotides.Influencing the fates of CD4 T cells on the path to memory: lessons from influenza.A heterologous helper T-cell epitope enhances the immunogenicity of a multiple-antigenic-peptide vaccine targeting the cryptic loop-neutralizing determinant of Bacillus anthracis protective antigen.Cytolytic CD4 cells: Direct mediators in infectious disease and malignancy.Micro and nanoparticle-based delivery systems for vaccine immunotherapy: an immunological and materials perspective.Immunotherapeutic potential of CpG oligodeoxynucleotides in veterinary species.Recent progress concerning CpG DNA and its use as a vaccine adjuvant.Peptide-based vaccination and induction of CD8+ T-cell responses against tumor antigens in breast cancer.Multiple antigen peptide containing B and T cell epitopes of F1 antigen of Yersinia pestis showed enhanced Th1 immune response in murine model.CpG-C ISS-ODN activation of blood-derived B cells from healthy and chronic immunodeficiency virus-infected macaques.
P2860
Q28392248-F1A32D77-BD73-4400-B7B1-64B01EA608A8Q33505445-B030697A-4AFE-491D-AA4C-1BA1A8E7AFCDQ33576071-DED2CE45-A75E-42DE-84D4-E187B20456BBQ33698106-58448A31-694B-4E3A-97CC-ED166F29CDD4Q33746872-E60717DB-8792-4699-9ABC-45BB21841E7FQ33797188-0AFB5E23-985D-4725-AB5E-E8BD82FB6512Q34400322-BECE6AE8-2B4B-493E-95C4-AABD684465B4Q35025722-8ECC8AE1-C136-44EF-9AAA-B22281A2E71BQ35853440-8903BEB3-EF6F-4E0B-9DDD-A62DA1239357Q35895400-059A77EC-7B5A-418D-8260-3E97CCCC4427Q36226066-B5D866EA-779A-4DDB-B638-2B91C095EAC5Q36530221-DB0B1827-5F0A-4996-852C-F23438A32505Q36673656-1BD5FC42-348A-4B2C-A7E7-D7C16688083DQ36733960-312B8C3A-1738-4EF2-811B-2E862E67C365Q36882257-D1252EEF-B068-4C6F-BF91-BF795BF0E04CQ36924602-2692EFBD-631E-48A3-9237-5E2279CF0833Q36995537-1585D89A-AA29-4519-918A-76B6CAB66CD9Q37117567-F9570F66-06DC-49B7-8594-C8F42B07B573Q37451219-EDFA9C0F-2EC3-4517-AB8C-E5605600A623Q37710793-4CC6876D-75AB-4763-B239-0E9F77729466Q38066148-7DD91C88-93AB-4955-BC6D-5012B34C2C1DQ38131836-54B2A786-3DDF-4279-A038-8AC764A8115AQ38168903-0BFF6330-ED44-4C2A-9DF7-C00494ECBB18Q38293525-9D35BF5F-7453-46F2-BAF9-444055D7C72BQ41400297-4EA59B43-9532-4A66-8CDA-0C1EEC64CEF6Q45420331-95D0A0AA-2797-4112-90C9-77582E6E79FD
P2860
CpG oligonucleotides improve the protective immune response induced by the anthrax vaccination of rhesus macaques.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh-hant
name
CpG oligonucleotides improve t ...... accination of rhesus macaques.
@en
CpG oligonucleotides improve t ...... accination of rhesus macaques.
@nl
type
label
CpG oligonucleotides improve t ...... accination of rhesus macaques.
@en
CpG oligonucleotides improve t ...... accination of rhesus macaques.
@nl
prefLabel
CpG oligonucleotides improve t ...... accination of rhesus macaques.
@en
CpG oligonucleotides improve t ...... accination of rhesus macaques.
@nl
P2093
P1433
P1476
CpG oligonucleotides improve t ...... accination of rhesus macaques.
@en
P2093
Bruce E Ivins
Debra Currie
Dennis M Klinman
Stephen F Little
P304
P356
10.1016/J.VACCINE.2003.12.020
P407
P577
2004-07-01T00:00:00Z